Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FWKFR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,957
Award facts
- Contract value 100% obligated
- $29,956.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,956.96 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL quantities. This firm fixed-price delivery order, issued on August 25, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The contract was competitively awarded with no set-aside designation and is scheduled for completion by August 26, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for Ozempic, a diabetes medication, exemplifies the company's role in supplying brand-name pharmaceuticals to support the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FWKFR?
SPE2DB25FWKFR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FWKFR worth?
The government has obligated $29,957 on SPE2DB25FWKFR.
Is contract SPE2DB25FWKFR an order under another contract?
Yes. SPE2DB25FWKFR is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB25FWKFR competed?
The extent of competition for SPE2DB25FWKFR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award